Servier Offers $483 Million To Buy Rest Of Hungarian Generics Maker Egis
After holding a 51% stake in Egis for 18 years, France's mid-sized pharma company Servier is now offering nearly $483 million to buy the rest of the Hungarian generics company.
After holding a 51% stake in Egis for 18 years, France's mid-sized pharma company Servier is now offering nearly $483 million to buy the rest of the Hungarian generics company.